Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for dapagliflozin in Any Name (approximate match)

Showing 1 - 10 of 13 results

First page disabled
Previous page disabled
1
Next page
Next page

DAPAGLIFLOZIN

1ULL0QJ8UC

Search for Structure

Status:

US Approved Rx (2017)

Source:

NDA209091

(2017)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209091

First approved in 2008

Source:

NDA202293

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01f90c94-71cb-4a1f-81ff-8004b850529b

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Sodium/glucose cotransporter 2

Conditions:

Type 2 diabetes mellitus

Dapagliflozin (trade name Farxiga in the U.S. and Forxiga in the EU and Russia) is a drug of the gliflozin class, developed by Bristol-Myers Squibb in partnership with AstraZeneca. Farxiga is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Dapagliflozin C2 epimer

WK33WFE47M

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Dapagliflozin, (1R)-

V2NT58LK94

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

1,4-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol, (1S)-

YVU6XK9RBL

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

1,4-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol, (1R)-

7HCT755EVJ

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-α-D-glucopyranose

2GLW9C3QQ3

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Methoxy Dapagliflozin

BWH63G5PJQ

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

DAPAGLIFLOZIN 2,3-BUTANEDIOL MONOHYDRATE

U289305BKG

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (MIXED)

DAPAGLIFLOZIN 3-O-GLUCURONIDE

X42P3B148J

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

BMS-511926

00K1K06ADY

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Structure of DAPAGLIFLOZIN

ABSOLUTE

Structure of Dapagliflozin C2 epimer

ABSOLUTE

Dapagliflozin C2 epimer

Structure of Dapagliflozin, (1R)-

ABSOLUTE

Dapagliflozin, (1R)-

Structure of 1,4-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol, (1S)-

ABSOLUTE

1,4-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol, (1S)-

Structure of 1,4-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol, (1R)-

ABSOLUTE

1,4-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol, (1R)-

Structure of 1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-α-D-glucopyranose

ABSOLUTE

1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-α-D-glucopyranose

Structure of Methoxy Dapagliflozin

ABSOLUTE

Methoxy Dapagliflozin

Structure of DAPAGLIFLOZIN 2,3-BUTANEDIOL MONOHYDRATE

MIXED

DAPAGLIFLOZIN 2,3-BUTANEDIOL MONOHYDRATE

Structure of DAPAGLIFLOZIN 3-O-GLUCURONIDE

ABSOLUTE

DAPAGLIFLOZIN 3-O-GLUCURONIDE

Structure of BMS-511926

ABSOLUTE

Showing 1 - 10 of 13 results

First page disabled
Previous page disabled
1
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1